These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26346797)

  • 1. Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
    Fiest KM; Fisk JD; Patten SB; Tremlett H; Wolfson C; Warren S; McKay KA; Berrigan L; Marrie RA;
    Mult Scler Relat Disord; 2015 Sep; 4(5):470-476. PubMed ID: 26346797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of physical comorbidities on disability progression in multiple sclerosis.
    Zhang T; Tremlett H; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell T; Stadnyk K; Carruthers R; Wolfson C; Warren S; Marrie RA;
    Neurology; 2018 Jan; 90(5):e419-e427. PubMed ID: 29298855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.
    Salter A; Lancia S; Kowalec K; Fitzgerald KC; Marrie RA
    Neurology; 2024 Mar; 102(5):e209135. PubMed ID: 38350062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study.
    Dagnew B; Laslett LL; Honan CA; Blizzard L; Winzenberg T; Taylor BV; van der Mei I
    Mult Scler; 2024 Jun; 30(7):877-887. PubMed ID: 38738517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for observational studies of comorbidity in multiple sclerosis.
    Marrie RA; Miller A; Sormani MP; Thompson A; Waubant E; Trojano M; O'Connor P; Fiest K; Reider N; Reingold S; Cohen JA;
    Neurology; 2016 Apr; 86(15):1446-1453. PubMed ID: 26865523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
    Simpson RJ; McLean G; Guthrie B; Mair F; Mercer SW
    BMC Neurol; 2014 Jun; 14():128. PubMed ID: 24925477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emotional burden among MS patients: associations between specific chronic pain diagnoses and psychological features.
    Rivel M; Achiron A; Stern Y; Zeilig G; Defrin R
    J Neurol; 2024 Feb; 271(2):688-698. PubMed ID: 37875677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pain in multiple sclerosis: prevalence, mechanisms, types and treatment].
    Bermejo PE; Oreja-Guevara C; Díez-Tejedor E
    Rev Neurol; 2010 Jan 16-31; 50(2):101-8. PubMed ID: 20112218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There an Association Between Social Support and Pain Among Individuals Living With Multiple Sclerosis?
    Alphonsus KB; D'Arcy C
    J Evid Based Integr Med; 2021; 26():2515690X21991995. PubMed ID: 33535805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances.
    Marrie RA; Fisk JD; Fitzgerald K; Kowalec K; Maxwell C; Rotstein D; Salter A; Tremlett H
    Front Immunol; 2023; 14():1197195. PubMed ID: 37325663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of comorbidity in clinical trials for multiple sclerosis.
    Marrie RA; Miller A; Sormani MP; Thompson A; Waubant E; Trojano M; O'Connor P; Reingold S; Cohen JA;
    Neurology; 2016 Apr; 86(15):1437-1445. PubMed ID: 26888986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: Worrying data on excess mortality and comorbidity in MS.
    Malkki H
    Nat Rev Neurol; 2015 Oct; 11(10):546. PubMed ID: 26347368
    [No Abstract]   [Full Text] [Related]  

  • 13. Causes of death among persons with multiple sclerosis.
    Cutter GR; Zimmerman J; Salter AR; Knappertz V; Suarez G; Waterbor J; Howard VJ; Marrie RA
    Mult Scler Relat Disord; 2015 Sep; 4(5):484-490. PubMed ID: 26346799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
    Viana P; Rodrigues E; Fernandes C; Matas A; Barreto R; Mendonça M; Peralta R; Geraldes R
    Mult Scler Relat Disord; 2015 Sep; 4(5):477-483. PubMed ID: 26346798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining reliable disability outcomes in multiple sclerosis.
    Kalincik T; Cutter G; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Hupperts R; Oreja-Guevara C; Boz C; Pucci E; Bergamaschi R; Lechner-Scott J; Alroughani R; Van Pesch V; Iuliano G; Fernandez-Bolaños R; Ramo C; Terzi M; Slee M; Spitaleri D; Verheul F; Cristiano E; Sánchez-Menoyo JL; Fiol M; Gray O; Cabrera-Gomez JA; Barnett M; Butzkueven H
    Brain; 2015 Nov; 138(Pt 11):3287-98. PubMed ID: 26359291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
    Ramanujam R; Hedström AK; Manouchehrinia A; Alfredsson L; Olsson T; Bottai M; Hillert J
    JAMA Neurol; 2015 Oct; 72(10):1117-23. PubMed ID: 26348720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
    Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; Saccà F; Baroncini D; Comi G; Trojano M;
    Brain; 2015 Nov; 138(Pt 11):3275-86. PubMed ID: 26362907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
    Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
    J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise therapy for fatigue in multiple sclerosis.
    Heine M; van de Port I; Rietberg MB; van Wegen EE; Kwakkel G
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009956. PubMed ID: 26358158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
    Goldman MD; Stüve O
    JAMA Neurol; 2015 Oct; 72(10):1105-6. PubMed ID: 26348489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.